Publications by authors named "Gabriel Benchimol"

Claim this Profile
L
Learning and teaching ophthalmology in the pandemic.
Thiago Gonçalves Dos Santos Martins, Gabriel Lima Benchimol, Gustavo Rosa Gameiro, Paulo Schor

Einstein (Sao Paulo)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human placental perfusion measured using dynamic contrast enhancement MRI.
Benjamin Deloison, Chloé Arthuis, Gabriel Benchimol, Daniel Balvay, Laurence Bussieres

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore.
Enora Laas, Julie Labrosse, Anne-Sophie Hamy, Gabriel Benchimol, Diane de Croze

Br J Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major response to imatinib and chemotherapy in a newborn patient prenatally diagnosed with generalized infantile myofibromatosis.
Stéphanie Proust, Gabriel Benchimol, Sylvie Fraitag, Julie Starck, Vannina Giacobbi

Pediatr Blood Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A warning against associating doxycycline with isotretinoin.
Alexandre Xavier da Costa, Gabriel Lima Benchimol, Tulio Frade Reis

Arq Bras Oftalmol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between Molecular Subtypes and Stromal Immune Infiltration before and after Treatment in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Anne-Sophie Hamy, Hélène Bonsang-Kitzis, Diane De Croze, Enora Laas, Lauren Darrigues, Gabriel Benchimol

Clin Cancer Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial.
Anne-Sophie Hamy, Sandrine Tury, Xiaofei Wang, Junheng Gao, Jean-Yves Pierga, Gabriel Benchimol

J Clin Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.
Anne-Sophie Hamy, Giang-Thanh Lam, Enora Laas, Lauren Darrigues, Thomas Balezeau, Gabriel Benchimol

Breast Cancer Res Treat· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis